Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients
Volume: 21, Issue: 8, Pages: 2913 - 2915
Published: Aug 1, 2021
Abstract
To the Editor: Solid organ transplant (SOT) recipients represent a high-risk group for all SARS-CoV-2 infection-related adverse outcomes.1Williamson EJ Walker AJ Bhaskaran K et al.Factors associated with COVID-19-related death using Open SAFELY.Nature. 2020; 584: 430-436Crossref PubMed Scopus (3100) Google Scholar Therefore, most European countries have established prioritization of SOT recipients in their vaccination programs. Suboptimal...
Paper Details
Title
Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients
Published Date
Aug 1, 2021
Volume
21
Issue
8
Pages
2913 - 2915
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History